Vaccination with patient-specific tumor-derived antigen in first remission improves disease-free survival in follicular lymphoma

Stephen J. Schuster, Sattva S. Neelapu, Barry L. Gause, John E. Janik, Franco M. Muggia, Jon P. Gockerman, Jane N. Winter, Christopher R. Flowers, Daniel A. Nikcevich, Eduardo M. Sotomayor, Dean S. McGaughey, Elaine S. Jaffe, Elise A. Chong, Craig W. Reynolds, Donald A. Berry, Carlos F. Santos, Mihaela A. Popa, Amy M. McCord, Larry W. Kwak*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

199 Scopus citations

Fingerprint

Dive into the research topics of 'Vaccination with patient-specific tumor-derived antigen in first remission improves disease-free survival in follicular lymphoma'. Together they form a unique fingerprint.

Medicine and Dentistry

Agricultural and Biological Sciences

Immunology and Microbiology